Back

Disruptive arterial pressure stability is improved by sodium-glucose co-transporter 2 inhibitor in streptozotocin-induced diabetic rat

27 August 2016 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster session 5 - Dealing with metabolic disorders Diabetes, dysglycaemia and metabolic syndrome ESC Premium Access ESC Congress 2016

About the speaker

Photo
Doctor Tomoko Yoshikawa

Kyushu University Graduate School of Medical Sciences, Fukuoka (Japan)

19 More presentations in this session

Presentation thumbnail
Glycemic variability predicts left ventricular reverse remodeling in patients with ST-segment elevation acute myocardial infarction
Mr Y. Minamimoto (Yokohama, JP)
Abstract
Presentation thumbnail
Weight loss or exercise to improve insulin sensitivity in overweight CAD patients? One year follow-up in the randomised CUT-IT trial
Doctor L. Pedersen (Copenhagen, DK)
Abstract
Presentation thumbnail
Family history impact in the setting of the metabolic syndrome: the 40 year follow-up results of the seven countries study
Assistant Professor B. Parapid (Belgrade, RS)
Abstract
Presentation thumbnail
New role of lysosomal acid lipase in metabolic syndrome
Doctor A. Nohara (Kanazawa, JP)
Abstract
Presentation thumbnail
Non-alcoholic fatty liver disease strongly predicts incident diabetes in patients with coronary artery disease
Professor H. Drexel (Feldkirch, AT)
Abstract Slides

Access the full session

Session thumbnail
Poster session 5 - Dealing with metabolic disorders

The Event

Event poster

ESC Congress 2016

27 August - 31 August 2016

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources